CEO is doing a good job in his early years.

I am impressed with the revenue beat and meeting expectations on EPS. I would have been more concerned if beat by a penny and had weak revs.

The revenues here and at MDRX are proof that physicians are making the conversion.

I have checked with a few physicians in my area and most are planning on going to an EMR, some have purchased on are waiting for implementation.

I wonder if the EPS meet with higher revenues could be attributed to higher costs associated with making sure the transitions go as smoothly as possible. Or an increase in expenses related to employees hired to work on implementation.

Could also be additional sales reps -- when they are new to the territory might be more of an expense then revenue generator for first few months.

Either way, good results.

My compliments, esp considering ATHN couldn't hit their numbers.

I'd like to hear on the CC what they have in the pipeline and what they are feeling as far as sales closing over the next 2-3 qtrs.

One also has to remember that there is 17bil+ $$$ behind EMRs and the transition is coming and starting to flow in.
At a 38 PE I think this stock is cheap compared to its expected growth and for the premium that should be attached as I could see and big player like a JNJ, ORCL, SAP, DELL etc wanting in on this growth and paying to get it.